These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 22627901

  • 1. Depression and serotonin reuptake inhibitor treatment as risk factors for preterm birth.
    Yonkers KA, Norwitz ER, Smith MV, Lockwood CJ, Gotman N, Luchansky E, Lin H, Belanger K.
    Epidemiology; 2012 Sep; 23(5):677-85. PubMed ID: 22627901
    [Abstract] [Full Text] [Related]

  • 2. Pregnant women with posttraumatic stress disorder and risk of preterm birth.
    Yonkers KA, Smith MV, Forray A, Epperson CN, Costello D, Lin H, Belanger K.
    JAMA Psychiatry; 2014 Aug; 71(8):897-904. PubMed ID: 24920287
    [Abstract] [Full Text] [Related]

  • 3. Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study.
    Nordeng H, van Gelder MM, Spigset O, Koren G, Einarson A, Eberhard-Gran M.
    J Clin Psychopharmacol; 2012 Apr; 32(2):186-94. PubMed ID: 22367660
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S, Nourrisson A, Jaafari N, Pérault Pochat MC.
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [Abstract] [Full Text] [Related]

  • 5. Antidepressant use and preterm birth.
    Urato AC.
    Am J Psychiatry; 2009 Oct; 166(10):1189; author reply 1189-90. PubMed ID: 19797450
    [No Abstract] [Full Text] [Related]

  • 6. Mother-infant antidepressant concentrations, maternal depression, and perinatal events.
    Sit D, Perel JM, Wisniewski SR, Helsel JC, Luther JF, Wisner KL.
    J Clin Psychiatry; 2011 Jul; 72(7):994-1001. PubMed ID: 21824458
    [Abstract] [Full Text] [Related]

  • 7. Can nonrandomized studies on the safety of antidepressants during pregnancy convincingly beat confounding, chance, and prior beliefs?
    Palmsten K, Hernández-Díaz S.
    Epidemiology; 2012 Sep; 23(5):686-8. PubMed ID: 22872113
    [No Abstract] [Full Text] [Related]

  • 8. Birth weight and preterm birth in babies of pregnant women with major depression in relation to treatment with antidepressants.
    Şahingöz M, Yuksel G, Karsidag C, Uguz F, Sonmez EO, Annagur BB, Annagur A.
    J Clin Psychopharmacol; 2014 Apr; 34(2):226-9. PubMed ID: 24525643
    [Abstract] [Full Text] [Related]

  • 9. Neonatal Discontinuation Syndrome in Serotonergic Antidepressant-Exposed Neonates.
    Yang A, Ciolino JD, Pinheiro E, Rasmussen-Torvik LJ, Sit DKY, Wisner KL.
    J Clin Psychiatry; 2017 May; 78(5):605-611. PubMed ID: 28570796
    [Abstract] [Full Text] [Related]

  • 10. Sleep disturbances in depressed and nondepressed pregnant women.
    Okun ML, Kiewra K, Luther JF, Wisniewski SR, Wisner KL.
    Depress Anxiety; 2011 Aug; 28(8):676-85. PubMed ID: 21608086
    [Abstract] [Full Text] [Related]

  • 11. Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment.
    Salisbury AL, Wisner KL, Pearlstein T, Battle CL, Stroud L, Lester BM.
    Depress Anxiety; 2011 Nov; 28(11):1008-19. PubMed ID: 21898709
    [Abstract] [Full Text] [Related]

  • 12. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes.
    Wisner KL, Sit DK, Hanusa BH, Moses-Kolko EL, Bogen DL, Hunker DF, Perel JM, Jones-Ivy S, Bodnar LM, Singer LT.
    Am J Psychiatry; 2009 May; 166(5):557-66. PubMed ID: 19289451
    [Abstract] [Full Text] [Related]

  • 13. Pharmacotherapy for depressed pregnant women: overcoming obstacles to gathering essential data.
    Wisner KL, Appelbaum PS, Uhl K, Goldkind SF.
    Clin Pharmacol Ther; 2009 Oct; 86(4):362-5. PubMed ID: 19763116
    [Abstract] [Full Text] [Related]

  • 14. Impact of prenatal exposure to serotonin reuptake inhibitors or maternal major depressive disorder on infant developmental outcomes.
    Santucci AK, Singer LT, Wisniewski SR, Luther JF, Eng HF, Dills JL, Sit DK, Hanusa BH, Wisner KL.
    J Clin Psychiatry; 2014 Oct; 75(10):1088-95. PubMed ID: 25373117
    [Abstract] [Full Text] [Related]

  • 15. The serotonin reuptake inhibitor fluoxetine induces human fetal membrane sterile inflammation through p38 MAPK activation.
    Fabrizio VA, Lindsay CV, Wilcox M, Hong S, Lynn T, Norwitz ER, Yonkers KA, Abrahams VM.
    J Reprod Immunol; 2023 Feb; 155():103786. PubMed ID: 36528909
    [Abstract] [Full Text] [Related]

  • 16. Risk of preterm birth by subtype among Medi-Cal participants with mental illness.
    Baer RJ, Chambers CD, Bandoli G, Jelliffe-Pawlowski LL.
    Am J Obstet Gynecol; 2016 Oct; 215(4):519.e1-9. PubMed ID: 27329688
    [Abstract] [Full Text] [Related]

  • 17. Are maternal depression or symptom severity associated with breastfeeding intention or outcomes?
    Bogen DL, Hanusa BH, Moses-Kolko E, Wisner KL.
    J Clin Psychiatry; 2010 Aug; 71(8):1069-78. PubMed ID: 20584521
    [Abstract] [Full Text] [Related]

  • 18. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.
    El Marroun H, Jaddoe VW, Hudziak JJ, Roza SJ, Steegers EA, Hofman A, Verhulst FC, White TJ, Stricker BH, Tiemeier H.
    Arch Gen Psychiatry; 2012 Jul; 69(7):706-14. PubMed ID: 22393202
    [Abstract] [Full Text] [Related]

  • 19. The risks of selective serotonin reuptake inhibitor use in infertile women: a review of the impact on fertility, pregnancy, neonatal health and beyond.
    Domar AD, Moragianni VA, Ryley DA, Urato AC.
    Hum Reprod; 2013 Jan; 28(1):160-71. PubMed ID: 23117129
    [Abstract] [Full Text] [Related]

  • 20. Fine Motor Differences and Prenatal Serotonin Reuptake Inhibitors Exposure.
    Partridge MC, Salisbury AL, LaGasse LL.
    J Pediatr; 2016 Aug; 175():144-149.e1. PubMed ID: 27215778
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.